4//SEC Filing
BRYNJELSEN SEAN 4
Accession 0001493152-22-026629
CIK 0001710340other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 10:58 AM ET
Size
5.2 KB
Accession
0001493152-22-026629
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2022-09-22$2.10/sh+10,000$21,042→ 1,040,000 total
Holdings
- 24,940(indirect: By LLC)
Common Stock
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001669976
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 10:58 AM ET
- Size
- 5.2 KB